The HCV Revolution: Are You and Your Practice Ready?

This program will include a discussion of data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

The Importance of Recognizing HCV

Treating Patients in the Interferon Era

The DAA Era -- Path to the Cure First Generation

The DAA Era -- Path to the Cure First Generation (cont)

The DAA Era -- Path to the Cure Second Generation

The DAA Era -- Path to the Cure Second Generation (cont)

The DAA Era -- Path to the Cure Third Generation

The DAA Era -- Path to the Cure Practical Considerations

Guidelines for Treatment of Chronic HCV Infection

HCV-TARGET

Efficacy of DAAs in Clinical Practice Clinical Trial Data vs Real-World Experience

Real-World Data Build Confidence

Caring for Patients in the Current Era The Opportunity Is Here, the Time Is Now

New HCV Infections Nearly Tripled Over 5 Years

Changing Demographics The "Second Bump"

Support Services for Effective Treatment Outcomes

Treating HCV in People Who Inject Drugs Debunking the Myths

Treating HCV in People Who Inject Drugs What Do the Data Show?

Treating People Who Inject Drugs Practical Realities

Some Patients Will Need to Be Referred

Get Started It’s Not Difficult, and It’s Very Rewarding

Practical Strategies for Making HCV Care a Part of Your Practice

Concluding Remarks

Abbreviations